Sort
166,118 grants matching “stem cells”
Transgenic Core Facility
$1,024,561Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
The MYC Transcription Factor Network and the Path to Cancer
$1,024,317Robert Neil Eisenman · Fred Hutchinson Cancer Research Center · R35 · FY2019 · CA
Peptide Receptor Systems
$1,024,259Ted B Usdin · National Institute Of Mental Health · ZIA · FY2014 · MH
Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants
$1,024,198Dixon B Kaufman · University Of Wisconsin-Madison · U01 · FY2017 · AI
Validation of a Novel Genetic Model for Neural Regeneration
$1,024,170Edward W Scott · University Of Florida · RC2 · FY2010 · NS
3/3-Schizophrenia Genetics and Brain Somatic Mosaicism
$1,024,142Fred H Gage · Salk Institute For Biological Studies · U01 · FY2019 · MH
Center for Gamma-Ray Imaging
$1,024,053Lars R Furenlid · University Of Arizona · P41 · FY2015 · EB
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$1,023,811Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2022 · HL
Pre-clinical and clinical studies of NTBC and other compounds as potential treatments for albinism
$1,023,709Brian Brooks · National Eye Institute · ZIA · FY2020 · EY
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
$1,023,555James D Crapo · Biomimetix Jv, Llc · R44 · FY2016 · CA
Mechanisms Regulating Activity Dependent Synaptic Plasticity and Gene Expression
$1,023,369Andres Buonanno · Child Health And Human Development · Z01 · FY2007 · HD
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$1,023,118Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2023 · HL
Targeting tau for the development of novel Alzheimer's disease therapeutics
$1,022,579Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2021 · AG
Path to Commercialization of the first âoff the shelfâ T cell product
$1,022,567John Wilson · Viracyte, Llc · R44 · FY2019 · HL
Genomic Sunlight Dosimeters for Melanoma Prevention
$1,022,551Douglas E Brash · Yale University · P50 · FY2016 · CA
Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate Cancer
$1,022,522Vidya P Ramamurthy · Isoprene Pharmaceuticals, Inc. · R44 · FY2025 · CA
The Physiological Control of Body Size
$1,022,323Herman F Nijhout · Duke University · · FY2023 · BIO
SCHS, mitochondria, healthy aging and longevity
$1,021,935Gino A Cortopassi · University Of California At Davis · P01 · FY2014 · AG
Cellular Interactions with Thrombospondin
$1,021,874David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Novel Small-Molecule Therapies for CF
$1,021,850Alan S Verkman · University Of California, San Francisco · P30 · FY2016 · DK
Interrogation of individual cells to identify progenitor cells and their niches
$1,021,789Mark A Krasnow · Stanford University · U01 · FY2009 · HL
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,021,774Thomas R Hawn · University Of Washington · R33 · FY2020 · AI
Biological Analysis Core
$1,021,741Hemali Phatnani · Columbia University Health Sciences · U54 · FY2023 · AG
Genomic Sunlight Dosimeters for Melanoma Prevention
$1,021,612Douglas E Brash · Yale University · P50 · FY2014 · CA
Lymphoma Disease Discovery and Definition
$1,021,536Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA